2020/2021. school year |
R29.3 |
Abnormal posture |
97.5 |
84.7 |
118.4 |
101.1 |
125.0 |
118.6 |
135.1 |
119.1 |
160.3 |
121.7 |
139.7 |
114.6 |
M41 |
Scoliosis (structural) |
46.8 |
48.8 |
63.4 |
65.1 |
78.6 |
84.5 |
96.8 |
99.3 |
125.2 |
131.0 |
125.6 |
136.8 |
M42.0 |
Spinal osteochondrosis |
0.5 |
0.3 |
0.8 |
0.6 |
1.6 |
1.4 |
2.8 |
2.3 |
6.8 |
4.7 |
7.8 |
5.0 |
M91–M92 |
Chondropathies |
1.5 |
1.5 |
3.1 |
2.0 |
2.7 |
2.6 |
5.0 |
4.8 |
9.9 |
12.2 |
11.1 |
16.6 |
M21.4 |
Flat foot |
330.3 |
288.0 |
347.2 |
319.2 |
334.0 |
291.9 |
305.3 |
263.6 |
308.3 |
276.9 |
295.6 |
269.8 |
H52 |
Disorders of refraction and accomodation |
119.6 |
145.7 |
155.7 |
195.0 |
170.0 |
223.9 |
186.7 |
248.7 |
239.1 |
323.0 |
262.5 |
350.0 |
H49–H50 |
Strabismus |
6.6 |
6.5 |
6.4 |
6.8 |
5.5 |
6.8 |
4.9 |
4.6 |
5.2 |
5.0 |
3.8 |
4.7 |
H53.0 |
Amblyopia ex anopsia |
3.6 |
3.8 |
5.3 |
5.9 |
5.0 |
5.5 |
5.2 |
5.9 |
6.6 |
5.4 |
4.7 |
4.9 |
H53.5 |
Colour vision deficiencies |
5.0 |
0.6 |
8.7 |
0.7 |
31.4 |
2.2 |
28.1 |
1.6 |
27.6 |
1.1 |
27.0 |
1.2 |
H54 |
Blindness and low vision |
5.3 |
7.3 |
5.7 |
7.5 |
6.9 |
9.2 |
6.7 |
8.2 |
6.0 |
7.1 |
3.3 |
4.4 |
H90–H91 |
Conductive and sensorineural hearing loss |
6.1 |
5.1 |
6.4 |
5.9 |
6.3 |
6.2 |
6.0 |
5.5 |
8.6 |
5.9 |
7.1 |
5.3 |
I10; I15 |
Hypertensive diseases |
3.4 |
3.0 |
5.9 |
5.4 |
12.3 |
9.1 |
27.0 |
12.4 |
35.9 |
13.7 |
40.0 |
13.9 |
I01; I05–08; I42; Q20–Q28 |
Vitium (congenital, acquired) |
4.2 |
4.6 |
4.6 |
4.3 |
3.6 |
3.5 |
3.8 |
4.6 |
5.3 |
4.4 |
5.9 |
5.4 |
I44–I49; F45.3 |
Cardiac arrhytmies |
2.9 |
3.0 |
2.8 |
3.0 |
2.8 |
3.8 |
3.8 |
4.2 |
3.8 |
5.9 |
4.6 |
5.1 |
K50; K51 |
Noninfective enteritis and colitis |
0.1 |
0.3 |
0.5 |
0.2 |
0.6 |
0.6 |
0.9 |
0.8 |
1.8 |
1.5 |
1.5 |
1.7 |
K90.0; K90.4; K52.2; E73 |
Coeliac disease and other nutritional intolerance, allergy |
13.7 |
16.5 |
15.3 |
18.8 |
12.9 |
18.9 |
13.6 |
18.2 |
15.1 |
23.5 |
16.0 |
30.3 |
N00–N39 |
Chronic renal diseases |
1.4 |
1.4 |
1.6 |
1.3 |
2.0 |
1.2 |
1.3 |
1.3 |
1.9 |
2.7 |
2.3 |
2.7 |
Q55.0; Q55.2 |
Undescended testicle |
2.1 |
– |
1.2 |
– |
0.4 |
– |
0.3 |
– |
0.1 |
– |
0.1 |
– |
N91; N92 |
Absent, scanty and rare menstruation |
0.0 |
0.1 |
– |
0.4 |
– |
3.5 |
– |
9.0 |
– |
22.6 |
– |
23.2 |
E10 |
Diabetes mellitus |
1.3 |
1.9 |
2.1 |
2.3 |
2.9 |
2.8 |
3.7 |
3.4 |
3.4 |
4.8 |
3.8 |
5.1 |
E01; E02 |
Disorders of thyroid gland |
0.7 |
1.3 |
3.3 |
4.5 |
3.9 |
6.6 |
4.1 |
9.7 |
3.4 |
14.7 |
5.7 |
16.5 |
E66 |
Obesity |
128.3 |
124.8 |
146.4 |
134.6 |
152.0 |
129.4 |
146.7 |
125.6 |
154.7 |
134.6 |
151.9 |
128.1 |
E46 |
Unspecified protein-energy malnutrition |
21.4 |
23.2 |
20.8 |
23.9 |
23.4 |
24.8 |
25.7 |
20.4 |
22.9 |
25.9 |
16.9 |
26.4 |
E23; E45 |
Retarded growth |
4.8 |
5.4 |
4.9 |
4.8 |
5.2 |
4.1 |
4.6 |
5.3 |
2.8 |
7.2 |
2.8 |
6.1 |
D50–D64 |
Anaemia |
2.8 |
3.8 |
3.1 |
4.3 |
3.3 |
6.3 |
3.5 |
8.6 |
1.9 |
9.2 |
1.9 |
9.0 |
J45 |
Asthma |
23.7 |
15.1 |
26.3 |
16.3 |
29.1 |
19.7 |
27.2 |
21.0 |
28.4 |
23.6 |
26.6 |
25.8 |
J30.1–30.4 |
Allergic rhinitis |
26.8 |
21.1 |
31.3 |
25.7 |
38.4 |
30.7 |
41.1 |
33.7 |
58.9 |
49.0 |
63.1 |
55.2 |
T78.3; L20–L30 |
Angioneurotic oedema, dermatitis and eczema |
13.6 |
16.1 |
14.4 |
16.3 |
14.4 |
17.5 |
15.6 |
17.9 |
18.2 |
18.5 |
18.0 |
20.5 |
F45 |
Somatoform disorders |
2.4 |
1.2 |
3.1 |
1.9 |
3.3 |
2.4 |
2.6 |
2.8 |
3.4 |
5.3 |
2.8 |
4.6 |
F50; F51 |
Eating and nonorganic sleeping disorders |
0.8 |
0.7 |
1.0 |
1.0 |
1.4 |
1.6 |
1.3 |
2.4 |
2.0 |
4.8 |
2.2 |
4.5 |
F81 |
Specific developmental disorders of scholastic skills |
43.2 |
26.0 |
51.3 |
33.0 |
49.6 |
31.7 |
44.3 |
27.8 |
37.7 |
23.6 |
22.1 |
14.5 |
F90–F99 |
Behavioural and emotional disorders |
30.4 |
14.9 |
32.7 |
16.6 |
29.2 |
18.2 |
26.1 |
16.5 |
16.8 |
16.1 |
12.7 |
11.2 |
G40 |
Epilepsy |
2.7 |
3.2 |
4.3 |
2.5 |
3.8 |
3.3 |
3.9 |
2.8 |
3.7 |
4.3 |
3.3 |
4.0 |
G80–G83 |
Cerebral palsy and other paralytic syndrome |
1.5 |
1.4 |
2.1 |
1.1 |
1.7 |
1.6 |
1.6 |
1.8 |
1.8 |
1.5 |
1.0 |
1.2 |
2021/2022. school year |
R29.3 |
Abnormal posture |
104.6 |
91.8 |
125.1 |
112.5 |
138.1 |
125.8 |
148.8 |
126.1 |
165.3 |
125.4 |
146.0 |
116.3 |
M41 |
Scoliosis (structural) |
46.3 |
46.5 |
63.4 |
69.1 |
81.9 |
85.5 |
97.2 |
100.8 |
126.7 |
130.6 |
119.7 |
124.5 |
M42.0 |
Spinal osteochondrosis |
0.5 |
0.3 |
0.9 |
0.9 |
2.0 |
1.8 |
4.2 |
2.3 |
7.5 |
4.1 |
6.9 |
4.2 |
M91–M92 |
Chondropathies |
1.5 |
1.6 |
2.7 |
1.7 |
3.4 |
2.3 |
4.7 |
4.0 |
6.5 |
10.1 |
9.1 |
12.3 |
M21.4 |
Flat foot |
333.9 |
282.6 |
357.3 |
322.1 |
352.8 |
303.1 |
319.6 |
274.7 |
316.3 |
277.6 |
297.3 |
260.0 |
H52 |
Disorders of refraction and accomodation |
115.0 |
146.0 |
152.8 |
189.5 |
164.9 |
218.3 |
180.0 |
249.9 |
229.1 |
312.4 |
253.1 |
334.5 |
H49–H50 |
Strabismus |
7.2 |
8.1 |
6.7 |
6.3 |
5.9 |
6.5 |
5.0 |
5.7 |
4.3 |
5.0 |
3.9 |
4.4 |
H53.0 |
Amblyopia ex anopsia |
3.2 |
3.4 |
3.9 |
4.5 |
3.5 |
4.8 |
3.6 |
4.5 |
4.5 |
5.4 |
3.6 |
4.4 |
H53.5 |
Colour vision deficiencies |
5.6 |
0.5 |
8.7 |
0.9 |
34.3 |
3.3 |
28.2 |
1.3 |
24.9 |
1.6 |
22.3 |
0.9 |
H54 |
Blindness and low vision |
6.1 |
7.5 |
7.3 |
9.2 |
7.3 |
8.4 |
7.6 |
9.4 |
5.9 |
6.8 |
6.5 |
7.7 |
H90–H91 |
Conductive and sensorineural hearing loss |
6.3 |
6.3 |
6.2 |
5.8 |
6.1 |
5.5 |
5.6 |
5.8 |
7.6 |
6.5 |
6.3 |
5.9 |
I10; I15 |
Hypertensive diseases |
4.2 |
2.7 |
7.3 |
5.7 |
14.7 |
10.8 |
29.6 |
14.8 |
35.3 |
14.0 |
37.2 |
12.8 |
I01; I05–08; I42; Q20–Q28 |
Vitium (congenital, acquired) |
3.6 |
3.4 |
4.2 |
3.8 |
3.8 |
4.3 |
3.3 |
4.0 |
4.8 |
5.4 |
5.2 |
5.8 |
I44–I49; F45.3 |
Cardiac arrhytmies |
2.6 |
2.6 |
2.4 |
2.4 |
2.5 |
3.2 |
2.5 |
3.1 |
3.7 |
5.3 |
4.1 |
4.6 |
K50; K51 |
Noninfective enteritis and colitis |
0.4 |
0.1 |
0.4 |
0.4 |
0.9 |
0.4 |
0.9 |
0.9 |
1.1 |
1.8 |
1.9 |
2.3 |
K90.0; K90.4; K52.2; E73 |
Coeliac disease and other nutritional intolerance, allergy |
13.8 |
17.9 |
16.9 |
19.6 |
17.2 |
22.2 |
15.9 |
20.7 |
14.5 |
27.5 |
18.4 |
30.2 |
N00–N39 |
Chronic renal diseases |
2.0 |
1.4 |
2.0 |
1.7 |
2.0 |
1.4 |
1.6 |
1.4 |
2.1 |
2.0 |
2.0 |
2.0 |
Q55.0; Q55.2 |
Undescended testicle |
1.8 |
– |
1.3 |
– |
0.6 |
– |
0.2 |
– |
0.2 |
– |
0.2 |
– |
N91; N92 |
Absent, scanty and rare menstruation |
0.0 |
0.3 |
– |
0.6 |
– |
3.8 |
– |
11.8 |
– |
28.5 |
– |
25.6 |
E10 |
Diabetes mellitus |
1.5 |
1.9 |
2.3 |
2.6 |
2.8 |
2.7 |
3.9 |
3.3 |
4.3 |
3.8 |
4.4 |
4.4 |
E01; E02 |
Disorders of thyroid gland |
1.1 |
1.2 |
2.9 |
4.5 |
3.5 |
8.0 |
4.1 |
9.5 |
4.5 |
16.4 |
4.7 |
16.8 |
E66 |
Obesity |
127.0 |
123.6 |
154.2 |
133.7 |
152.1 |
128.9 |
151.6 |
128.4 |
157.5 |
127.1 |
156.0 |
127.4 |
E46 |
Unspecified protein-energy malnutrition |
24.5 |
23.3 |
24.6 |
24.5 |
25.2 |
24.3 |
24.2 |
20.4 |
27.7 |
28.1 |
20.5 |
28.7 |
E23; E45 |
Retarded growth |
5.4 |
4.6 |
5.6 |
4.5 |
5.4 |
4.8 |
5.0 |
5.2 |
3.1 |
5.7 |
2.5 |
4.8 |
D50–D64 |
Anaemia |
2.8 |
3.0 |
3.1 |
4.8 |
3.0 |
7.4 |
3.0 |
10.2 |
1.8 |
11.6 |
1.4 |
11.4 |
J45 |
Asthma |
22.5 |
15.9 |
25.9 |
17.3 |
26.5 |
18.3 |
24.9 |
18.1 |
25.4 |
23.5 |
23.3 |
20.9 |
J30.1–30.4 |
Allergic rhinitis |
26.7 |
19.5 |
37.1 |
27.4 |
40.5 |
31.9 |
43.3 |
35.2 |
57.6 |
46.3 |
62.9 |
48.4 |
T78.3; L20–L30 |
Angioneurotic oedema, dermatitis and eczema |
14.2 |
17.0 |
16.6 |
19.2 |
15.6 |
18.8 |
16.0 |
18.6 |
16.5 |
18.5 |
18.2 |
20.0 |
F45 |
Somatoform disorders |
2.0 |
1.2 |
2.5 |
2.1 |
2.8 |
2.8 |
2.6 |
3.2 |
3.9 |
6.1 |
5.4 |
5.3 |
F50; F51 |
Eating and nonorganic sleeping disorders |
1.9 |
2.1 |
2.5 |
2.3 |
2.4 |
2.7 |
2.5 |
4.0 |
2.7 |
7.4 |
2.8 |
7.0 |
F81 |
Specific developmental disorders of scholastic skills |
40.3 |
22.1 |
52.2 |
30.1 |
48.8 |
31.9 |
47.3 |
27.4 |
37.2 |
21.5 |
26.8 |
15.3 |
F90–F99 |
Behavioural and emotional disorders |
30.4 |
14.6 |
36.7 |
18.9 |
34.7 |
22.1 |
29.3 |
19.0 |
21.5 |
18.0 |
14.2 |
12.5 |
G40 |
Epilepsy |
3.1 |
2.7 |
3.8 |
2.8 |
3.6 |
3.1 |
3.7 |
2.9 |
4.0 |
3.6 |
3.6 |
3.1 |
G80–G83 |
Cerebral palsy and other paralytic syndrome |
1.0 |
1.2 |
1.7 |
0.9 |
1.2 |
0.7 |
1.6 |
1.4 |
1.2 |
1.2 |
1.5 |
1.2 |
2022/2023. scool year |
R29.3 |
Abnormal posture |
109.4 |
90.7 |
131.6 |
112.2 |
141.8 |
129.2 |
149.0 |
126.6 |
178.2 |
136.8 |
153.0 |
116.6 |
M41 |
Scoliosis (structural) |
49.3 |
50.5 |
65.5 |
66.2 |
83.6 |
88.5 |
100.8 |
100.8 |
130.6 |
131.1 |
124.8 |
125.5 |
M42.0 |
Spinal osteochondrosis |
0.5 |
0.5 |
0.8 |
0.6 |
2.0 |
1.8 |
4.5 |
2.5 |
7.6 |
3.6 |
8.0 |
4.5 |
M91–M92 |
Chondropathies |
1.4 |
0.9 |
2.3 |
1.3 |
3.2 |
2.6 |
5.2 |
4.0 |
7.8 |
10.2 |
8.1 |
10.2 |
M21.4 |
Flat foot |
337.8 |
285.1 |
357.1 |
322.4 |
356.3 |
306.6 |
323.3 |
274.3 |
329.8 |
286.0 |
307.8 |
262.2 |
H52 |
Disorders of refraction and accomodation |
119.2 |
148.7 |
153.8 |
197.6 |
169.8 |
215.7 |
179.8 |
239.9 |
227.1 |
301.0 |
253.6 |
333.3 |
H49–H50 |
Strabismus |
7.8 |
7.5 |
6.9 |
7.5 |
5.4 |
6.1 |
4.8 |
5.6 |
5.3 |
5.3 |
4.4 |
5.0 |
H53.0 |
Amblyopia ex anopsia |
3.1 |
3.5 |
3.2 |
4.1 |
3.8 |
4.0 |
3.9 |
4.2 |
3.9 |
4.2 |
4.1 |
3.5 |
H53.5 |
Colour vision deficiencies |
5.6 |
0.7 |
8.2 |
1.2 |
34.8 |
3.4 |
28.0 |
2.0 |
27.2 |
1.2 |
22.6 |
1.2 |
H54 |
Blindness and low vision |
4.7 |
5.3 |
5.3 |
7.0 |
6.2 |
6.2 |
7.6 |
7.4 |
6.4 |
6.3 |
4.8 |
7.0 |
H90–H91 |
Conductive and sensorineural hearing loss |
7.8 |
5.2 |
6.8 |
5.6 |
6.6 |
6.2 |
6.4 |
5.4 |
7.8 |
6.4 |
7.8 |
5.9 |
I10; I15 |
Hypertensive diseases |
4.2 |
3.1 |
7.6 |
6.1 |
14.5 |
10.4 |
27.8 |
14.9 |
33.1 |
13.5 |
40.9 |
12.7 |
I01; I05–08; I42; Q20–Q28 |
Vitium (congenital, acquired) |
3.9 |
3.9 |
3.9 |
4.0 |
3.9 |
3.8 |
4.0 |
4.1 |
4.9 |
5.6 |
5.2 |
4.9 |
I44–I49; F45.3 |
Cardiac arrhytmies |
2.6 |
2.9 |
2.6 |
2.5 |
3.0 |
3.6 |
2.4 |
3.0 |
3.4 |
4.0 |
3.8 |
3.8 |
K50; K51 |
Noninfective enteritis and colitis |
0.3 |
0.4 |
0.3 |
0.3 |
0.8 |
0.4 |
0.9 |
0.8 |
1.9 |
2.0 |
2.6 |
2.7 |
K90.0; K90.4; K52.2; E73 |
Coeliac disease and other nutritional intolerance, allergy |
16.2 |
19.4 |
16.4 |
20.9 |
17.4 |
22.1 |
15.5 |
22.7 |
16.7 |
30.7 |
17.5 |
30.9 |
N00–N39 |
Chronic renal diseases |
2.7 |
1.6 |
1.8 |
1.6 |
1.9 |
1.2 |
1.8 |
1.3 |
2.5 |
2.4 |
1.6 |
2.2 |
Q55.0; Q55.2 |
Undescended testicle |
2.4 |
– |
1.3 |
– |
0.6 |
– |
0.4 |
– |
0.2 |
– |
0.3 |
– |
N91; N92 |
Absent, scanty and rare menstruation |
0.0 |
0.1 |
– |
0.4 |
– |
4.5 |
– |
11.9 |
– |
29.1 |
– |
28.8 |
E10 |
Diabetes mellitus |
1.6 |
2.0 |
1.7 |
2.1 |
3.3 |
2.9 |
3.4 |
3.0 |
4.9 |
3.6 |
4.0 |
4.1 |
E01; E02 |
Disorders of thyroid gland |
0.8 |
1.8 |
3.4 |
5.1 |
3.7 |
7.5 |
3.9 |
10.1 |
4.3 |
13.5 |
4.3 |
17.5 |
E66 |
Obesity |
122.3 |
110.8 |
155.6 |
126.0 |
161.3 |
126.1 |
149.4 |
123.4 |
158.4 |
128.4 |
160.9 |
135.5 |
E46 |
Unspecified protein-energy malnutrition |
23.1 |
20.4 |
20.9 |
22.7 |
25.1 |
21.8 |
23.8 |
18.5 |
22.9 |
24.1 |
16.6 |
22.8 |
E23; E45 |
Retarded growth |
6.6 |
5.9 |
5.6 |
5.3 |
6.4 |
5.0 |
5.4 |
4.1 |
3.9 |
5.2 |
2.6 |
4.4 |
D50–D64 |
Anaemia |
2.7 |
3.2 |
3.7 |
4.6 |
3.7 |
8.1 |
3.5 |
12.4 |
2.0 |
12.2 |
2.0 |
12.4 |
J45 |
Asthma |
22.9 |
15.3 |
25.9 |
17.7 |
26.0 |
17.2 |
24.7 |
17.9 |
27.0 |
22.5 |
23.0 |
22.0 |
J30.1–30.4 |
Allergic rhinitis |
27.7 |
20.4 |
37.7 |
28.1 |
42.5 |
34.1 |
47.7 |
36.0 |
57.6 |
45.5 |
60.9 |
47.6 |
T78.3; L20–L30 |
Angioneurotic oedema, dermatitis and eczema |
13.0 |
16.3 |
14.7 |
19.5 |
16.4 |
18.2 |
15.8 |
17.9 |
17.8 |
20.3 |
17.5 |
19.8 |
F45 |
Somatoform disorders |
2.5 |
1.9 |
3.3 |
2.5 |
2.8 |
2.5 |
2.2 |
3.1 |
4.6 |
6.2 |
3.5 |
5.2 |
F50; F51 |
Eating and nonorganic sleeping disorders |
1.5 |
1.5 |
1.5 |
1.9 |
1.7 |
2.3 |
1.4 |
3.4 |
2.5 |
6.3 |
2.8 |
6.6 |
F81 |
Specific developmental disorders of scholastic skills |
39.9 |
23.0 |
45.5 |
28.2 |
49.5 |
31.3 |
43.8 |
27.1 |
34.9 |
21.2 |
24.2 |
15.3 |
F90–F99 |
Behavioural and emotional disorders |
31.6 |
15.5 |
34.7 |
18.3 |
36.1 |
20.0 |
26.8 |
21.0 |
21.2 |
20.0 |
15.9 |
13.7 |
G40 |
Epilepsy |
3.1 |
2.5 |
3.5 |
2.9 |
4.1 |
3.5 |
3.5 |
3.4 |
4.6 |
4.4 |
3.7 |
3.8 |
G80–G83 |
Cerebral palsy and other paralytic syndrome |
1.7 |
1.4 |
1.2 |
1.4 |
1.6 |
1.2 |
1.5 |
1.5 |
1.7 |
1.1 |
1.5 |
1.1 |
2023/2024. scool year |
R29.3 |
Abnormal posture |
115.6 |
94.2 |
135.6 |
109.3 |
147.7 |
125.1 |
151.1 |
128.0 |
186.0 |
144.6 |
158.7 |
121.2 |
M41 |
Scoliosis (structural) |
46.8 |
47.4 |
63.1 |
64.5 |
80.6 |
88.2 |
101.5 |
105.9 |
124.1 |
132.1 |
125.3 |
133.5 |
M42.0 |
Spinal osteochondrosis |
0.4 |
0.2 |
0.8 |
0.7 |
1.6 |
1.8 |
2.9 |
2.5 |
7.5 |
5.2 |
6.8 |
3.9 |
M91–M92 |
Chondropathies |
1.6 |
0.6 |
1.6 |
1.6 |
3.2 |
2.1 |
4.3 |
3.6 |
8.1 |
11.0 |
8.3 |
12.8 |
M21.4 |
Flat foot |
346.1 |
299.7 |
354.4 |
315.9 |
362.6 |
304.1 |
330.1 |
276.5 |
327.3 |
280.0 |
306.0 |
261.8 |
H52 |
Disorders of refraction and accomodation |
121.1 |
145.2 |
146.7 |
188.8 |
165.9 |
214.7 |
176.5 |
239.3 |
222.8 |
296.0 |
247.5 |
325.2 |
H49–H50 |
Strabismus |
7.9 |
7.0 |
6.8 |
6.4 |
5.3 |
5.2 |
4.8 |
5.1 |
5.2 |
5.4 |
5.0 |
4.3 |
H53.0 |
Amblyopia ex anopsia |
3.4 |
3.0 |
3.2 |
4.1 |
4.3 |
4.7 |
4.2 |
4.6 |
3.5 |
4.0 |
3.3 |
3.9 |
H53.5 |
Colour vision deficiencies |
5.6 |
0.3 |
9.8 |
0.9 |
36.0 |
2.9 |
26.6 |
1.7 |
26.3 |
1.2 |
20.7 |
1.3 |
H54 |
Blindness and low vision |
6.0 |
7.3 |
7.1 |
6.9 |
5.5 |
7.3 |
7.4 |
8.6 |
6.7 |
5.5 |
6.2 |
4.8 |
H90–H91 |
Conductive and sensorineural hearing loss |
8.2 |
6.7 |
6.4 |
6.0 |
7.2 |
5.5 |
6.3 |
6.0 |
7.3 |
6.5 |
6.9 |
5.3 |
I10; I15 |
Hypertensive diseases |
3.8 |
3.8 |
7.4 |
6.0 |
14.6 |
10.4 |
28.8 |
12.9 |
33.3 |
13.0 |
40.2 |
13.6 |
I01; I05–08; I42; Q20–Q28 |
Vitium (congenital, acquired) |
4.0 |
3.5 |
3.7 |
3.1 |
4.1 |
3.6 |
4.3 |
4.2 |
5.8 |
5.8 |
5.3 |
4.8 |
I44–I49; F45.3 |
Cardiac arrhytmies |
2.6 |
2.6 |
2.2 |
2.8 |
3.3 |
3.2 |
3.3 |
3.3 |
3.3 |
4.6 |
2.9 |
3.8 |
K50; K51 |
Noninfective enteritis and colitis |
0.3 |
0.4 |
0.6 |
0.2 |
0.8 |
1.0 |
1.2 |
0.9 |
2.0 |
2.1 |
2.3 |
2.4 |
K90.0; K90.4; K52.2; E73 |
Coeliac disease and other nutritional intolerance, allergy |
16.2 |
18.0 |
17.5 |
21.3 |
17.0 |
22.7 |
16.5 |
23.8 |
20.0 |
33.8 |
19.6 |
35.7 |
N00–N39 |
Chronic renal diseases |
2.8 |
1.3 |
2.4 |
1.2 |
2.2 |
1.3 |
2.0 |
1.7 |
2.3 |
2.0 |
2.1 |
2.5 |
Q55.0; Q55.2 |
Undescended testicle |
2.5 |
– |
1.2 |
– |
0.7 |
– |
0.3 |
– |
0.3 |
– |
0.2 |
– |
N91; N92 |
Absent, scanty and rare menstruation |
0.0 |
0.1 |
– |
0.3 |
– |
3.6 |
– |
13.6 |
– |
27.2 |
– |
27.6 |
E10 |
Diabetes mellitus |
1.9 |
1.6 |
2.3 |
2.7 |
3.0 |
3.1 |
3.3 |
3.0 |
4.9 |
4.5 |
4.3 |
4.6 |
E01; E02 |
Disorders of thyroid gland |
0.8 |
1.4 |
1.8 |
3.0 |
3.6 |
6.4 |
3.7 |
9.3 |
4.1 |
15.7 |
4.1 |
17.0 |
E66 |
Obesity |
118.2 |
108.6 |
152.4 |
124.5 |
161.0 |
124.8 |
147.7 |
123.6 |
158.0 |
126.4 |
159.7 |
134.4 |
E46 |
Unspecified protein-energy malnutrition |
21.5 |
21.6 |
21.6 |
22.2 |
21.8 |
23.1 |
21.9 |
18.9 |
19.1 |
23.6 |
17.3 |
23.7 |
E23; E45 |
Retarded growth |
8.5 |
7.9 |
6.6 |
6.8 |
8.9 |
7.3 |
7.1 |
7.9 |
6.4 |
9.6 |
3.7 |
7.2 |
D50–D64 |
Anaemia |
2.9 |
3.9 |
2.8 |
4.7 |
4.2 |
9.7 |
3.9 |
13.7 |
1.9 |
12.7 |
1.9 |
13.1 |
J45 |
Asthma |
22.4 |
14.9 |
24.8 |
17.3 |
25.9 |
17.9 |
24.7 |
17.2 |
25.2 |
21.6 |
24.0 |
22.6 |
J30.1–30.4 |
Allergic rhinitis |
28.2 |
22.0 |
36.3 |
26.2 |
48.6 |
36.0 |
46.1 |
38.9 |
62.9 |
49.2 |
71.3 |
52.8 |
T78.3; L20–L30 |
Angioneurotic oedema, dermatitis and eczema |
15.1 |
17.8 |
15.5 |
19.2 |
17.0 |
19.5 |
17.1 |
19.7 |
19.6 |
21.2 |
19.6 |
21.4 |
F45 |
Somatoform disorders |
2.3 |
1.0 |
2.1 |
1.6 |
2.1 |
2.6 |
2.3 |
3.4 |
4.9 |
6.1 |
3.1 |
5.1 |
F50; F51 |
Eating and nonorganic sleeping disorders |
1.7 |
1.8 |
1.5 |
1.3 |
2.0 |
2.7 |
1.8 |
4.2 |
2.3 |
6.8 |
2.7 |
6.2 |
F81 |
Specific developmental disorders of scholastic skills |
46.9 |
26.1 |
44.9 |
27.6 |
50.2 |
30.6 |
47.6 |
31.5 |
39.1 |
24.2 |
23.7 |
16.1 |
F90–F99 |
Behavioural and emotional disorders |
36.6 |
16.6 |
31.1 |
17.9 |
35.0 |
21.9 |
33.5 |
24.0 |
21.8 |
21.8 |
14.3 |
17.3 |
G40 |
Epilepsy |
3.3 |
2.7 |
4.1 |
3.1 |
3.6 |
2.8 |
4.0 |
3.7 |
4.2 |
4.0 |
3.4 |
3.4 |
G80–G83 |
Cerebral palsy and other paralytic syndrome |
1.6 |
1.0 |
1.4 |
1.2 |
1.3 |
0.8 |
1.5 |
1.5 |
1.2 |
1.0 |
1.4 |
1.1 |